Top Markets
Coin of the day
Acura Pharmaceuticals, Inc. Acura Pharmaceuticals, Inc.

Acura Pharmaceuticals, Inc.

ACUR
Rankning i aktier #41977
Acura Pharmaceuticals, Inc. operates as a drug delivery innovator, dedicated to... Acura Pharmaceuticals, Inc. operates as a drug delivery innovator, dedicated to exploring, developing, and bringing to market novel technologies and products aimed at enhancing medication safety across the United States. Its product portfolio features Oxaydo tablets, a potent Schedule II narcotic prescribed for managing both acute and chronic moderate-to-severe pain. The company also offers the Nexafed line, consisting of pseudoephedrine and acetaminophen tablets, widely utilized as nasal decongestants in a range of over-the-counter and prescription formulations for cold, sinus, and allergy relief. Beyond its current offerings, Acura is actively advancing six additional opioid products through various stages of formulation development. To support its global reach, Acura Pharmaceuticals maintains strategic collaboration and licensing agreements with Egalet US, Inc. and Egalet Ltd. for the worldwide production and commercialization of its Oxaydo products. Furthermore, it has established a development and commercialization partnership with Abuse Deterrent Pharma, LLC to create LTX-03, an immediate-release tablet leveraging the proprietary LIMITx technology. Established in 1935, the company's operations are headquartered in Palatine, Illinois.
Aktiekurs
$0.0001
Senast synkroniserad: 2026-08-11
Marknadsvärde
$6.60K
Förändring (1 dag)
-50.00%
Förändring (1 år)
-80.00%
Land
US
Handel Acura Pharmaceuticals, Inc. (ACUR)

Kategori

Vinst för Acura Pharmaceuticals, Inc. (ACUR)
Vinst i 2026 TTM: 0
Enligt de senaste finansiella rapporterna från Acura Pharmaceuticals, Inc. är företagets nuvarande vinst 0. År 2026 hade företaget en vinst på 0, lika med vinsten år 2026 som var 0. Vinsten som visas på denna sida är vinsten före räntor och skatt, även kallad EBIT.
Vinshistorik för Acura Pharmaceuticals, Inc. från 2026 till 2026
Vinst vid slutet av varje år
År Vinst Ändra
Inte tillräckligt med data för de angivna datumen.
Vinst för liknande företag eller konkurrenter